Provided by Tiger Fintech (Singapore) Pte. Ltd.

Edwards Lifesciences

69.20
-2.3300-3.26%
Post-market: 69.200.00000.00%17:53 EDT
Volume:3.77M
Turnover:261.27M
Market Cap:40.53B
PE:9.93
High:71.20
Open:71.20
Low:68.63
Close:71.53
Loading ...

Edwards Lifesciences Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
1 hour ago

Significant Portfolio Changes: UnitedHealth Group Inc Sees Major Reduction by Eaton Vance ...

GuruFocus.com
·
6 hours ago

Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW) and Legend Biotech (LEGN)

TIPRANKS
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD), UnitedHealth (UNH) and Edwards Lifesciences (EW)

TIPRANKS
·
Yesterday

Eight-Year Data Confirm Long-Term Durability of Edwards’ RESILIA Tissue

Business Wire
·
18 Apr

RBC Capital Sticks to Their Buy Rating for Edwards Lifesciences (EW)

TIPRANKS
·
17 Apr

Barclays Flags Medtronic, J&J as Most at Risk from Looming Pharma Tariffs

GuruFocus.com
·
17 Apr

Press Release: Edwards Lifesciences to Host Earnings Conference Call on April 23, 2025

Dow Jones
·
16 Apr

Hold Rating Maintained for Edwards Lifesciences Amidst Positive Developments in Mitral Valve Approval and TAVR Challenges

TIPRANKS
·
16 Apr

Edwards Lifesciences Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
16 Apr

Balanced Outlook on Edwards Lifesciences Amid TMTT Growth and TAVR Market Challenges

TIPRANKS
·
15 Apr

Edwards Lifesciences Gets CE Mark for Sapien M3 Mitral Valve System

MT Newswires Live
·
14 Apr

BRIEF-Edwards Sapien M3 Receives CE Mark, Becoming World’S First Transfemoral Transcatheter Mitral Valve Replacement System

Reuters
·
14 Apr

Edwards Lifesciences receives CE Mark for Sapien M3

TIPRANKS
·
14 Apr

Edwards Sapien M3 Receives Ce Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System

THOMSON REUTERS
·
14 Apr

Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System

Business Wire
·
14 Apr

Edwards Lifesciences Corp. Stock Rises Friday, Still Underperforms Market

Dow Jones
·
12 Apr

Truist Cuts Price Target on Edwards Lifesciences to $75 From $78, Keeps Hold Rating

MT Newswires Live
·
11 Apr

Edwards Lifesciences Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
09 Apr

Trump Tariffs Will Sow Long-term Structural Dislocation, Oppenheimer Says

MT Newswires Live
·
08 Apr